The addition of urinary SMTNL2 methylation to a multivariate model (which adjusted for eGFR and albumin:creatinine ratio amongst other parameters) significantly improved the discrimination of patients with DKD and faster rates of eGFR decline [25]. The gene discussed is ALB; the disease is diabetic kidney disease.